The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Immune checkpoint HLA-E:CD94-NKG2A mediates evasion of circulating tumor cells from NK cell surveillance
Open accessAbstract
Circulating tumor cells (CTCs), shed by primary malignancies, function as "seeds" for distant metastasis. However, it is still largely unknown how CTCs escape immune surveillance. Here, we characterize the transcriptomes of human pancreatic ductal adenocarcinoma CTCs, primary, and metastatic lesions at single-cell scale. Cell-interaction analysis and functional studies in vitro and in vivo reveal that CTCs and natural killer (NK) cells interact via the immune checkpoint molecule pair HLA-E:CD94-NKG2A. Disruption of this interaction by blockade of NKG2A or knockdown of HLA-E expression enhances NK-mediated tumor cell killing in vitro and prevents tumor metastasis in vivo. Mechanistic studies indicate that platelet-derived RGS18 promotes the expression of HLA-E through AKT-GSK3β-CREB signaling, and overexpression of RGS18 facilitates pancreatic tumor hepatic metastasis. In conclusion, platelet-derived RGS18 protects CTCs from NK-mediated immune surveillance by engaging the immune checkpoint HLA-E:CD94-NKG2A. Interruption of the suppressive signaling prevents tumor metastasis in vivo by immune elimination of CTCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fast and accurate short read alignment with Burrows-Wheeler transform
Li, H., & Durbin, R. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp324 · Cited by 58,607
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
The Genome Analysis Toolkit: A MapReduce framework for analyzing next-generation DNA sequencing data
McKenna, A., Hanna, M., Banks, E., Sivachenko, A., Cibulskis, K., Kernytsky, A., Garimella, K., Altshuler, D., Gabriel, S., Daly, M., et al. (2010) · Genome Research · doi:10.1101/gr.107524.110 · Cited by 27,895
Siegel, R. L., Miller, K. D., Fuchs, H. E., & Jemal, A. (2021) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21654 · Cited by 16,522
Integrated analysis of multimodal single-cell data
Hao, Y., Hao, S., Andersen-Nissen, E., Mauck, W. M., Zheng, S., Butler, A., Lee, M. J., Wilk, A. J., Darby, C., Zagar, M., et al. (2020) · doi:10.1101/2020.10.12.335331 · Cited by 15,508
ANNOVAR: functional annotation of genetic variants from high-throughput sequencing data
Wang, K., Li, M., & Hakonarson, H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq603 · Cited by 14,621
Complex heatmaps reveal patterns and correlations in multidimensional genomic data
Gu, Z., Eils, R., & Schlesner, M. (2016) · Bioinformatics · doi:10.1093/bioinformatics/btw313 · Cited by 10,034
Inference and analysis of cell-cell communication using CellChat
Jin, S., Guerrero-Juarez, C. F., Zhang, L., Chang, I., Ramos, R., Kuan, C.-H., Myung, P., Plikus, M. V., & Nie, Q. (2021) · Nature Communications · doi:10.1038/s41467-021-21246-9 · Cited by 8,409
Safety and activity of anti-PD-L1 antibody in patients with advanced cancer
Brahmer, J. R., Tykodi, S. S., Chow, L. Q. M., Hwu, W.-J., Topalian, S. L., Hwu, P., Drake, C. G., Camacho, L. H., Kauh, J., Odunsi, K., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200694 · Cited by 7,945
Molecular signatures database (MSigDB) 3.0
Liberzon, A., Subramanian, A., Pinchback, R., Thorvaldsdóttir, H., Tamayo, P., & Mesirov, J. P. (2011) · Bioinformatics · doi:10.1093/bioinformatics/btr260 · Cited by 7,111
Bindea, G., Mlecnik, B., Hackl, H., Charoentong, P., Tosolini, M., Kirilovsky, A., Fridman, W.-H., Pagès, F., Trajanoski, Z., & Galon, J. (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp101 · Cited by 6,280
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Mayakonda, A., Lin, D.-C., Assenov, Y., Plass, C., & Koeffler, H. P. (2018) · Genome Research · doi:10.1101/gr.239244.118 · Cited by 4,935
The future of immune checkpoint therapy
Sharma, P., & Allison, J. P. (2015) · Science · doi:10.1126/science.aaa8172 · Cited by 4,878
circlize implements and enhances circular visualization in R
Gu, Z., Gu, L., Eils, R., Schlesner, M., & Brors, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu393 · Cited by 4,246
Efremova, M., Vento-Tormo, M., Teichmann, S. A., & Vento-Tormo, R. (2020) · Nature Protocols · doi:10.1038/s41596-020-0292-x · Cited by 3,449
Fundamental Mechanisms of Immune Checkpoint Blockade Therapy
Wei, S. C., Duffy, C. R., & Allison, J. P. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-18-0367 · Cited by 3,088
Emerging Biological Principles of Metastasis
Lambert, A. W., Pattabiraman, D. R., & Weinberg, R. A. (2017) · Cell · doi:10.1016/j.cell.2016.11.037 · Cited by 3,067
HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C
Braud, V. M., Allan, D. S. J., O'Callaghan, C. A., Söderström, K., D'Andrea, A., Ogg, G. S., Lazetic, S., Young, N. T., Bell, J. I., Phillips, J. H., et al. (1998) · Nature · doi:10.1038/35869 · Cited by 2,227
Contribution of platelets to tumour metastasis
Gay, L. J., & Felding-Habermann, B. (2011) · Nature Reviews Cancer · doi:10.1038/nrc3004 · Cited by 1,645
Isolation of circulating tumor cells using a microvortex-generating herringbone-chip
Stott, S. L., Hsu, C.-H., Tsukrov, D. I., Yu, M., Miyamoto, D. T., Waltman, B. A., Rothenberg, S. M., Shah, A. M., Smas, M. E., Korir, G. K., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1012539107 · Cited by 1,634
Full-length mRNA-Seq from single-cell levels of RNA and individual circulating tumor cells
Ramsköld, D., Luo, S., Wang, Y.-C., Li, R., Deng, Q., Faridani, O. R., Daniels, G. A., Khrebtukova, I., Loring, J. F., Laurent, L. C., et al. (2012) · Nature Biotechnology · doi:10.1038/nbt.2282 · Cited by 1,609
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
Sanmamed, M. F., & Chen, L. (2018) · Cell · doi:10.1016/j.cell.2018.09.035 · Cited by 1,392
Neutrophils escort circulating tumour cells to enable cell cycle progression
Szczerba, B. M., Castro-Giner, F., Vetter, M., Krol, I., Gkountela, S., Landin, J., Scheidmann, M. C., Donato, C., Scherrer, R., Singer, J., et al. (2019) · Nature · doi:10.1038/s41586-019-0915-y · Cited by 1,225
Ganesh, K., & Massagué, J. (2021) · Nature Medicine · doi:10.1038/s41591-020-01195-4 · Cited by 1,051
Delineating copy number and clonal substructure in human tumors from single-cell transcriptomes
Gao, R., Bai, S., Henderson, Y. C., Lin, Y., Schalck, A., Yan, Y., Kumar, T., Hu, M., Sei, E., Davis, A., et al. (2021) · Nature Biotechnology · doi:10.1038/s41587-020-00795-2 · Cited by 917
Best, M. G., Sol, N., Kooi, I., Tannous, J., Westerman, B. A., Rustenburg, F., Schellen, P., Verschueren, H., Post, E., Koster, J., et al. (2015) · Cancer Cell · doi:10.1016/j.ccell.2015.09.018 · Cited by 916
Sequenza: allele-specific copy number and mutation profiles from tumor sequencing data
Favero, F., Joshi, T., Marquard, A. M., Birkbak, N. J., Krzystanek, M., Li, Q., Szallasi, Z., & Eklund, A. C. (2015) · Annals of Oncology · doi:10.1093/annonc/mdu479 · Cited by 836
Plaks, V., Koopman, C. D., & Werb, Z. (2013) · Science · doi:10.1126/science.1235226 · Cited by 722
A microfluidic device for label-free, physical capture of circulating tumor cell clusters
Sarioglu, A. F., Aceto, N., Kojic, N., Donaldson, M. C., Zeinali, M., Hamza, B., Engstrom, A., Zhu, H., Sundaresan, T. K., Miyamoto, D. T., et al. (2015) · Nature Methods · doi:10.1038/nmeth.3404 · Cited by 709
Cancer Immunotherapy Update: FDA-Approved Checkpoint Inhibitors and Companion Diagnostics
Twomey, J. D., & Zhang, B. (2021) · The AAPS Journal · doi:10.1208/s12248-021-00574-0 · Cited by 657
Circulating and disseminated tumour cells — mechanisms of immune surveillance and escape
Mohme, M., Riethdorf, S., & Pantel, K. (2017) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2016.144 · Cited by 602
Multimodal mapping of the tumor and peripheral blood immune landscape in human pancreatic cancer
Steele, N. G., Carpenter, E. S., Kemp, S. B., Sirihorachai, V. R., The, S., Delrosario, L., Lazarus, J., Amir, E.-A. D., Gunchick, V., Espinoza, C., et al. (2020) · Nature Cancer · doi:10.1038/s43018-020-00121-4 · Cited by 546
Ting, D. T., Wittner, B. S., Ligorio, M., Vincent Jordan, N., Shah, A. M., Miyamoto, D. T., Aceto, N., Bersani, F., Brannigan, B. W., Xega, K., et al. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.029 · Cited by 527
Labelle, M., & Hynes, R. O. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0329 · Cited by 486
The clinical trial landscape for PD1/PDL1 immune checkpoint inhibitors
Tang, J., Yu, J. X., Hubbard-Lucey, V. M., Neftelinov, S. T., Hodge, J. P., & Lin, Y. (2018) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2018.210 · Cited by 382
Stromal biology and therapy in pancreatic cancer: ready for clinical translation?
Neesse, A., Bauer, C. A., Öhlund, D., Lauth, M., Buchholz, M., Michl, P., Tuveson, D. A., & Gress, T. M. (2019) · Gut · doi:10.1136/gutjnl-2018-316451 · Cited by 353
NKG2A Blockade Potentiates CD8 T Cell Immunity Induced by Cancer Vaccines
van Montfoort, N., Borst, L., Korrer, M. J., Sluijter, M., Marijt, K. A., Santegoets, S. J., van Ham, V. J., Ehsan, I., Charoentong, P., André, P., et al. (2018) · Cell · doi:10.1016/j.cell.2018.10.028 · Cited by 333
Duchez, A.-C., Boudreau, L. H., Naika, G. S., Bollinger, J., Belleannée, C., Cloutier, N., Laffont, B., Mendoza-Villarroel, R. E., Lévesque, T., Rollet-Labelle, E., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507905112 · Cited by 246
Sun, Y.-F., Wu, L., Liu, S.-P., Jiang, M.-M., Hu, B., Zhou, K.-Q., Guo, W., Xu, Y., Zhong, Y., Zhou, X.-R., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-24386-0 · Cited by 220
Advanced-stage pancreatic cancer: therapy options
Werner, J., Combs, S. E., Springfeld, C., Hartwig, W., Hackert, T., & Büchler, M. W. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.66 · Cited by 218
Deregulation of HLA-I in cancer and its central importance for immunotherapy
Hazini, A., Fisher, K., & Seymour, L. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-002899 · Cited by 203
SciBet as a portable and fast single cell type identifier
Li, C., Liu, B., Kang, B., Liu, Z., Liu, Y., Chen, C., Ren, X., & Zhang, Z. (2020) · Nature Communications · doi:10.1038/s41467-020-15523-2 · Cited by 176
Catenacci, D. V. T., Chapman, C. G., Xu, P., Koons, A., Konda, V. J. A., Siddiqui, U. D., & Waxman, I. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.08.050 · Cited by 165
Platelets, immune cells and the coagulation cascade; friend or foe of the circulating tumour cell?
Ward, M. P., E. Kane, L., A. Norris, L., Mohamed, B. M., Kelly, T., Bates, M., Clarke, A., Brady, N., Martin, C. M., Brooks, R. D., et al. (2021) · Molecular Cancer · doi:10.1186/s12943-021-01347-1 · Cited by 159
Transcriptional regulation of the MHC class Ib genes HLA-E, HLA-F, and HLA-G
Gobin, S. J. P., & van den Elsen, P. J. (2000) · Human Immunology · doi:10.1016/s0198-8859(00)00198-1 · Cited by 152
Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy
Hu, M., Wang, Y., Xu, L., An, S., Tang, Y., Zhou, X., Li, J., Liu, R., & Huang, L. (2019) · Nature Communications · doi:10.1038/s41467-019-10893-8 · Cited by 135
Pont, F., Tosolini, M., & Fournié, J. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz601 · Cited by 133
Tumor-derived circulating endothelial cell clusters in colorectal cancer
Cima, I., Kong, S. L., Sengupta, D., Tan, I., Phyo, W. M., Lee, D. C., Hu, M. S., Iliescu, C., Alexander, I., Goh, W. L., et al. (2016) · Science Translational Medicine · doi:10.1126/scitranslmed.aad7369 · Cited by 126
The hepatic pre-metastatic niche in pancreatic ductal adenocarcinoma
Houg, D. S., & Bijlsma, M. F. (2018) · Molecular Cancer · doi:10.1186/s12943-018-0842-9 · Cited by 122
AR Expression in Breast Cancer CTCs Associates with Bone Metastases
Aceto, N., Bardia, A., Wittner, B. S., Collier, M. D., OʼKeefe, R., Engstrom, A., Bersani, F., Zheng, Y., Comaills, V., Niederhoffer, K., et al. (2018) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-17-0480 · Cited by 110
Robert, C., Hwu, W., Hamid, O., Ribas, A., Weber, J. S., DAUD, A. I., Hodi, F. S., Wolchok, J. D., Mitchell, T. C., Hersey, P., et al. (2020) · European Journal of Cancer · doi:10.1016/j.ejca.2020.11.010 · Cited by 107
Yu, J., Xiao, W., Dong, S., Liang, H., Zhang, Z., Zhang, B., Huang, Z., Chen, Y.-F., Zhang, W., Luo, H., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4744-4 · Cited by 96
Pancreatic circulating tumor cell profiling identifies LIN28B as a metastasis driver and drug target
Franses, J. W., Philipp, J., Missios, P., Bhan, I., Liu, A., Yashaswini, C. N., Tai, E. C., Zhu, H., Ligorio, M., Nicholson, B., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17150-3 · Cited by 91
Law, H. C.-H., Lagundžin, D., Clement, E. J., Qiao, F., Wagner, Z. S., Krieger, K. L., Costanzo-Garvey, D. L., Caffrey, T. C., Grem, J. L., DiMaio, D. J., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-19-1496 · Cited by 73
Regulator of G-protein signaling 18 integrates activating and inhibitory signaling in platelets
Gegenbauer, K., Elia, G., Blanco, A., & Smolenski, A. (2012) · Blood · doi:10.1182/blood-2011-11-390369 · Cited by 64
A novel regulator of G-protein signaling bearing GAP activity for Gαi and Gαq in megakaryocytes
Nagata, Y., Oda, M., Nakata, H., Shozaki, Y., Kozasa, T., & Todokoro, K. (2001) · Blood · doi:10.1182/blood.v97.10.3051 · Cited by 50
Green, T. L., Cruse, J. M., & Lewis, R. E. (2013) · Experimental and Molecular Pathology · doi:10.1016/j.yexmp.2013.06.013 · Cited by 39
Bhan, I., Mosesso, K. M., Goyal, L., Philipp, J., Kalinich, M., Franses, J. W., Choz, M., Öklü, R., Toner, M., Maheswaran, S., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.09.020 · Cited by 37
Hamid, O., Robert, C., DAUD, A. I., Carlino, M. S., Mitchell, T. C., Hersey, P., Schachter, J., Long, G. V., Hodi, F. S., Wolchok, J. D., et al. (2021) · European Journal of Cancer · doi:10.1016/j.ejca.2021.08.013 · Cited by 25
Cited by
The hallmarks of cancer immune evasion
Galassi, C., Chan, T. A., Vitale, I., & Galluzzi, L. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.09.010 · Cited by 565
Vivier, E., Rebuffet, L., Narni-Mancinelli, E., Cornen, S., Igarashi, R. Y., & Fantin, V. R. (2024) · Nature · doi:10.1038/s41586-023-06945-1 · Cited by 467
Immune evasion in cancer: mechanisms and cutting-edge therapeutic approaches
Tufail, M., Jiang, C.-H., & Li, N. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02280-1 · Cited by 363
Shi, X., Wang, X., Yao, W., Shi, D., Shao, X., Lu, Z., Chai, Y., Song, J., Tang, W., & Wang, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01885-2 · Cited by 258
Self-citationTargeting MHC-I molecules for cancer: function, mechanism, and therapeutic prospects
Wu, X., Li, T., Jiang, R., Yang, X., Guo, H., & Yang, R. (2023) · Molecular Cancer · doi:10.1186/s12943-023-01899-4 · Cited by 223
“Liu et al. uncovered that hijacking the immune checkpoint HLA-E:NKG2A can prompt circulating cancer cells to escape from NK cells [32].”
BackgroundSelf-citation
Metadata
- Authors
- Liu, X., Song, J., Zhang, H., Liu, X., Zuo, F., Zhao, Y., Zhao, Y., Yin, X., Guo, X., Wu, X., Zhang, H., Xu, J., Hu, J., Jing, J., Ma, X., & Shi, H.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2023-02
- Volume
- 41
- Issue
- 2
- Pages
- 272-287.e9
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W4318070649
- Cited by
- 357
- References
- 59
- FWCI
- 31.39
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.